Tag Archives: Federal Circuit

AUTM Panel To Address A “Myriad” Of Challenges

Robert S. MacWright, J.D., Ph.D., the new head of tech transfer at the Salk Institute, will moderate a panel at the 2011 Annual Meeting of the Association of University Technology Managers (AUTM) on March 1st in Las Vegas.  The panel, … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , , , | Leave a comment

ACLU Files Its Brief in Myriad – Argues DNA Is A Blueprint Without a Name

On November 30, 2010, the ACLU filed its brief at the Federal Circuit in AMP et al. v. USPTO and Myriad Genetics, Inc. et al. If you have been reading my posts on this suit, you are by now probably … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , | Leave a comment

Astrazeneca v Apotex – Patent That Label!

I recently had a chance to re-read AstraZeneca LP v. Apotex, Inc., Appeal No. 2009-1381, 1424 (Fed. Cir. Nov. 1, 2010) and realized that it is a virtual case note on how to extend patent term by “patenting the label.” … Continue reading

Posted in Hatch-Waxman | Tagged , , , , , , , , , , , , | 1 Comment

Judge Goes Medieval On Spoilating Defendants

This summary of Victor Stanley v. Creative Pipe et al., provided by Ron Schutz of Robins, Kaplan, Miller & Ciresi is a cautionary tale for patent prosecutors served with subpoenas (or about to be). If the appropriate steps are not … Continue reading

Posted in Litigation Issues | Tagged , , , , , , , , , , , | Leave a comment